Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

N/A

2(100.0%)

2Total

N/A(2)

Loading network data...

Showing 6 of 6 trials

Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR)

Role: collaborator

Sarcopenic Obesity as a Risk of Premature Aging

Role: lead

Patient Reported Outcomes Following Cancer of the Rectum

Role: collaborator

3D-QFR in Non-selected Angiographic Stenosis. A Spanish Multicentre Study.

Role: collaborator

Coronariography in OUt of hosPital Cardiac arrEst

Role: collaborator

Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2).

Role: collaborator

All 6 trials loaded